BioHarvest Sciences Inc. Common Stock (BHST) は上場企業です 素材 セクターの Agricultural Inputs 業界で事業展開. 本社所在地は Vancouver, BC, カナダ. 現CEOは Ilan Sobel.
BHST を有する IPO日 2021-01-08, 87 名の正社員, に上場 NASDAQ Global Market, 時価総額 $73.99M.
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
